About Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern
During the past decade, Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Genomic Health®, Inc." with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "NanoString Technologies, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern
According to Clinical.Site data, the most researched conditions in "Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern" are
"Breast Cancer" (3 trials) and "Breast Cancer Female" (1 trials). Many other conditions were trialed in "Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern" in a lesser frequency.
Clinical Trials Intervention Types at Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern
Most popular intervention types in "Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib 50 MG; 150mg 1-0-1 per os" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Epirubicin" (1 trials) and "Induction therapy" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern
The vast majority of trials in "Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern" are
4 trials for "Female" genders.
Clinical Trials Status at Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern
Currently, there are NaN active trials in "Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".